How to Evaluate and Qualify and API Paracetamol Supplier

Choosing the right Paracetamol API supplier is critical for ensuring product quality, regulatory compliance, and supply continuity. This blog outlines a practical procurement checklist covering GMP compliance, quality systems, audits, documentation, supply reliability, and risk management. Learn how to evaluate suppliers beyond certifications and identify partners that deliver consistency, transparency, and long-term value. Discover how Farmson Basic Drugs supports procurement teams with trusted quality, regulatory readiness, and dependable supply.

For More Information Visit: https://www.farmson.com/blogs/how-to-evaluate-and-qualify-an-api-paracetamol-supplier/

Caffeine + Paracetamol Combination Formulations – What Pharma Manufacturers Need to Know

Paracetamol and caffeine combinations continue to gain attention for their enhanced analgesic benefits and broad use in headache, migraine, and cold & flu formulations. This blog explores how caffeine acts as an adjuvant to improve pain relief, the formulation challenges manufacturers must address, and why API quality is critical to product performance. Learn how consistent, compatible Paracetamol and Caffeine APIs can simplify development, improve scalability, and support reliable, high-quality combination formulations.

For More Information Visit: https://www.farmson.com/blogs/caffeine-paracetamol-combination-formulations-what-pharma-manufacturers-need-to-know/

Paracetamol DC vs. Wet Granulation - Which Process is Right for Your Tablet Formulation?

 

Choosing between Direct Compression and Wet Granulation can significantly impact tablet performance, manufacturing efficiency, and production costs. This blog explores the key differences between these two formulation approaches, highlighting the advantages and limitations of each. Learn how modern Paracetamol DC grades simplify production, improve consistency, and support faster scale-up, while wet granulation continues to offer benefits for specific formulations. Discover how Farmson’s Paracetamol DC helps manufacturers achieve reliable, high-quality tablet production.

For More Information Visit: https://www.farmson.com/blogs/paracetamol-dc-vs-wet-granulation/

Farmson Wins Platinum at Apex India Green Leaf Awards 2025

Farmson Basic Drugs proudly receives the Platinum Award at the Apex India Green Leaf Awards 2025, recognizing its commitment to sustainable pharmaceutical manufacturing. This milestone reflects years of effort in eco-friendly practices, energy efficiency, and responsible growth. By integrating sustainability into every operation from Paracetamol to new ventures like Caffeine Farmson reinforces its vision of delivering high-quality APIs while building a greener, more responsible future for global healthcare.

For More Information Visit: https://www.farmson.com/blogs/farmson-wins-platinum-at-apex-india-green-leaf-awards-2025/

What Makes Directly Compressible (DC) Granules a Competitive Advantage in Tablet Manufacturing?

Directly Compressible (DC) granules are transforming tablet manufacturing by simplifying processes, reducing costs, and improving consistency. By eliminating wet granulation, DC granules enable faster production, lower energy use, and better batch uniformity. Farmson’s Paracetamol DC granules, produced using advanced GLATT technology, deliver superior flow, compressibility, and scalability. With multiple grades and customization options, they provide a reliable, high-performance solution for efficient and competitive tablet manufacturing.

For More Information Visit: https://www.farmson.com/blogs/what-makes-directly-compressible-dc-granules-a-competitive-advantage-in-tablet-manufacturing/

Why India is Becoming a Global Hub for Paracetamol API and Caffeine API Manufacturing

 

India has emerged as one of the world’s most important pharmaceutical manufacturing hubs, particularly in the production of Active Pharmaceutical Ingredients (APIs). Among the most widely used APIs globally is Paracetamol, a key ingredient in many pain relief and fever medications.

Leading pharmaceutical companies are increasingly relying on trusted Paracetamol API Manufacturers in India for consistent quality and global regulatory compliance. Companies such as Farmson Basic Drugs have played an important role in strengthening India’s reputation as a reliable supplier of pharmaceutical ingredients.

In addition to traditional APIs, the industry is also seeing growing demand for Paracetamol DC (Directly Compressible) granules, which simplify tablet manufacturing processes. This has led to the rise of specialized Paracetamol DC Manufacturers in India who provide advanced pharmaceutical solutions for formulation companies.

Another important ingredient gaining attention is Caffeine API, widely used in pharmaceutical formulations and healthcare products. As demand grows, pharmaceutical manufacturers are expanding their capabilities to become reliable Caffeine API Manufacturers in India.

With strong regulatory standards, advanced manufacturing facilities, and a commitment to quality, Indian pharmaceutical manufacturers continue to support global healthcare companies with essential APIs. This makes India one of the most important global sources for Paracetamol, Caffeine, and other pharmaceutical ingredients.

For More Information Visit: https://www.farmson.com/

Research & Development - Driving Innovation at Farmson

Research & Development is the engine behind Farmson’s long-term success in pharmaceutical manufacturing. With a dedicated, state-of-the-art R&D center, Farmson develops innovative, non-infringing processes for APIs and DC granules while ensuring global regulatory readiness. Supported by advanced synthesis, analytical, and formulation facilities, Farmson’s R&D drives cost-effective, scalable, and sustainable solutions. Through continuous innovation and collaborative development, Farmson strengthens its API portfolio and delivers high-quality medicines to global markets.

For More Information Visit: https://www.farmson.com/blogs/research-development-driving-innovation-at-farmson/

Global Leadership in Paracetamol API Production

Farmson Basic Drugs is the world’s largest integrated manufacturer of Paracetamol API, with over five decades of leadership and a capacity of 53,000 MTPA—equivalent to 96.1 billion tablets annually. Supplying nearly 40% of India’s demand and exporting to 65+ countries, Farmson combines backward integration, multiple formulation grades, and global regulatory approvals. Its commitment to quality, innovation, and reliability has made Farmson the trusted backbone of paracetamol-based medicines worldwide.

For More Information Visit: https://www.farmson.com/blogs/global-leadership-in-paracetamol-api-production/

Farmson’s Commitment to Sustainability in Pharma Manufacturing

Farmson Basic Drugs embeds sustainability at the heart of pharmaceutical manufacturing through eco-friendly, solvent-free processes, renewable energy adoption, and responsible resource management. From solar power and cogeneration to water recycling and material recovery systems, Farmson actively reduces its environmental footprint. Backed by ethical sourcing, community initiatives, and efficient operations, the company proves that high-quality pharma manufacturing can go hand in hand with environmental stewardship and long-term sustainability.

For More Information Visit: https://www.farmson.com/blogs/farmsons-commitment-to-sustainability-in-pharma-manufacturing/

Expanding the API Portfolio - Farmson’s New API Offerings

Farmson Basic Drugs is expanding beyond paracetamol with a growing portfolio of high-demand APIs across respiratory, cardiovascular, urology, and nutritional therapies. New offerings such as Theophylline, Mirabegron, Folic Acid, Levosalbutamol, Theobromine, and Rivaroxaban reflect Farmson’s commitment to quality, compliance, and innovation. Backed by strong R&D, scalable facilities, and global regulatory standards, this expansion enables customers to source multiple critical APIs from one trusted partner.

For More Information Visit: https://www.farmson.com/blogs/expanding-the-api-portfolio-farmsons-new-api-offerings/